JP2001507022A5 - - Google Patents

Download PDF

Info

Publication number
JP2001507022A5
JP2001507022A5 JP1998528673A JP52867398A JP2001507022A5 JP 2001507022 A5 JP2001507022 A5 JP 2001507022A5 JP 1998528673 A JP1998528673 A JP 1998528673A JP 52867398 A JP52867398 A JP 52867398A JP 2001507022 A5 JP2001507022 A5 JP 2001507022A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998528673A
Other languages
English (en)
Japanese (ja)
Other versions
JP4488538B2 (ja
JP2001507022A (ja
Filing date
Publication date
Priority claimed from SE9604795A external-priority patent/SE9604795D0/xx
Application filed filed Critical
Publication of JP2001507022A publication Critical patent/JP2001507022A/ja
Publication of JP2001507022A5 publication Critical patent/JP2001507022A5/ja
Application granted granted Critical
Publication of JP4488538B2 publication Critical patent/JP4488538B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP52867398A 1996-12-20 1997-12-11 凍結乾燥のための医薬組成物 Expired - Lifetime JP4488538B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9604795A SE9604795D0 (sv) 1996-12-20 1996-12-20 New pharmaceutical formulation
SE9604795-6 1996-12-20
PCT/SE1997/002068 WO1998028009A1 (en) 1996-12-20 1997-12-11 Pharmaceutical compositions for freeze drying

Publications (3)

Publication Number Publication Date
JP2001507022A JP2001507022A (ja) 2001-05-29
JP2001507022A5 true JP2001507022A5 (https=) 2005-08-11
JP4488538B2 JP4488538B2 (ja) 2010-06-23

Family

ID=20405148

Family Applications (1)

Application Number Title Priority Date Filing Date
JP52867398A Expired - Lifetime JP4488538B2 (ja) 1996-12-20 1997-12-11 凍結乾燥のための医薬組成物

Country Status (35)

Country Link
US (1) US6114313A (https=)
EP (1) EP1007094B1 (https=)
JP (1) JP4488538B2 (https=)
KR (1) KR100552880B1 (https=)
CN (1) CN1121875C (https=)
AR (1) AR010377A1 (https=)
AT (1) ATE221787T1 (https=)
AU (1) AU758857B2 (https=)
BR (1) BR9713974B1 (https=)
CA (1) CA2275153C (https=)
CZ (1) CZ300635B6 (https=)
DE (1) DE69714616T2 (https=)
DK (1) DK1007094T3 (https=)
EE (1) EE03857B1 (https=)
ES (1) ES2182133T3 (https=)
FR (1) FR15C0060I2 (https=)
HU (1) HU226616B1 (https=)
ID (1) ID21635A (https=)
IL (1) IL130449A0 (https=)
IS (1) IS1897B (https=)
MY (1) MY121982A (https=)
NO (1) NO327142B1 (https=)
NZ (1) NZ336027A (https=)
PL (1) PL190493B1 (https=)
PT (1) PT1007094E (https=)
RU (1) RU2205012C2 (https=)
SA (1) SA97180719B1 (https=)
SE (1) SE9604795D0 (https=)
SI (1) SI1007094T1 (https=)
SK (1) SK283137B6 (https=)
TR (1) TR199901412T2 (https=)
TW (1) TW522015B (https=)
UA (1) UA66779C2 (https=)
WO (1) WO1998028009A1 (https=)
ZA (1) ZA9711055B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702680D0 (sv) * 1997-07-11 1997-07-11 Astra Pharma Prod New formulation
US9427448B2 (en) 2009-11-11 2016-08-30 The Medicines Company Methods of treating, reducing the incidence of, and/or preventing ischemic events
US8759316B2 (en) 2008-05-13 2014-06-24 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
WO2009140092A1 (en) 2008-05-13 2009-11-19 The Medicines Company Maintenance of platelet inhibition during antiplatelet therapy
US20120141468A1 (en) * 2008-05-13 2012-06-07 Lisa Ruderman Chen Maintenance of platelet inhibition during antiplatelet therapy
US20130303477A1 (en) 2008-05-13 2013-11-14 The Medicines Company Maintenance of Platelet Inhibition During Antiplatelet Therapy
US10376532B2 (en) 2009-11-11 2019-08-13 Chiesi Farmaceutici, S.P.A. Methods of treating, reducing the incidence of, and/or preventing ischemic events
BR112012011298B1 (pt) 2009-11-11 2021-12-14 Chiesi Farmaceutici S.P.A. Uso de cangrelor e/ou bivalirudina na preparação de medicamentos e combinação de medicamentos
JP5947316B2 (ja) 2011-02-09 2016-07-06 ザ メディシンズ カンパニー 肺高血圧症を処置するための方法
EA034550B1 (ru) 2013-03-09 2020-02-19 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Способы лечения, снижения частоты и/или профилактики ишемических событий
CN103772461A (zh) * 2014-01-06 2014-05-07 南京正科制药有限公司 一种坎格雷洛晶型ⅰ
CN115990138A (zh) 2015-01-14 2023-04-21 奇斯药制品公司 包含高纯度坎格雷洛的药物制剂以及制备和使用它们的方法
MA49452A (fr) 2017-06-23 2021-05-05 Chiesi Farm Spa Procédé de prévention de thrombose de shunt de l'artère systémique-pulmonaire

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5637967B2 (https=) * 1973-05-17 1981-09-03
JPH01228915A (ja) * 1988-03-09 1989-09-12 Dai Ichi Seiyaku Co Ltd Atp凍結乾燥製剤
GB8903593D0 (en) * 1989-02-16 1989-04-05 Pafra Ltd Storage of materials
CZ281415B6 (cs) * 1989-11-09 1996-09-11 Masarykova Nemocnice S Poliklinikou Iii. Typu Způsob přípravy přenosového faktoru z buffy coatu savčí krve
GB9010742D0 (en) * 1990-05-14 1990-07-04 Quadrant Bioresources Ltd Stabilization of biological macromolecular substances
AU659645B2 (en) * 1991-06-26 1995-05-25 Inhale Therapeutic Systems Storage of materials
ES2129048T3 (es) * 1991-12-09 1999-06-01 Asahi Chemical Ind Composicion estabilizada de hormona paratiroide.
KR100315612B1 (ko) * 1993-02-10 2002-06-20 추후제출 N-알킬-2-치환아데노신트리포스페이트동족체

Similar Documents

Publication Publication Date Title
JP2000502280A5 (https=)
JP2000501771A5 (https=)
JP2001517383A5 (https=)
JP2000501599A5 (https=)
JP2000501018A5 (https=)
JP2000508206A5 (https=)
JP2000501324A5 (https=)
JP2000508006A5 (https=)
JP2000502472A5 (https=)
JP2000501825A5 (https=)
JP2000501338A5 (https=)
JP2001501132A5 (https=)
JP2000502485A5 (https=)
JP2000502425A5 (https=)
JP2000502568A5 (https=)
JP2000501774A5 (https=)
JP2000502570A5 (https=)
JP2001505334A5 (https=)
JP2001501612A5 (https=)
JP2000501876A5 (https=)
JP2000501744A5 (https=)
JP2000509492A5 (https=)
JP2000501229A5 (https=)
JP2000502316A5 (https=)
JP2000502714A5 (https=)